![PRD_002454 PRD_002454](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002454.svg) | PRD_002454 | Name: | Substrate-like cysteine protease inhibitor | Formula: | C46 H70 Cl N10 O9 | Definition date: | 2021-09-01 | Last modified: | 2021-09-01 |
|
![PRD_002469 PRD_002469](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002469.svg) | PRD_002469 | Name: | Inhibitor 18 | Formula: | C30 H42 N4 O6 | Definition date: | 2021-08-25 | Last modified: | 2021-08-25 |
|
![PRD_002457 PRD_002457](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002457.svg) | PRD_002457 | Name: | beta-D-glucopyranose-(1-4)-beta-D-glucopyranose-(1-3)-2-deoxy-2-fluoro-alpha-D-glucopyranose | Formula: | C18 H31 F O15 | Definition date: | 2021-05-19 | Last modified: | 2021-05-19 |
|
![PRD_002377 PRD_002377](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/U5Y.svg) | PRD_002377 | Name: | (12S,15S)-N-[(2-fluorophenyl)methyl]-10,13-dioxo-12-{2-oxo-2-[(2R)-2-phenylpyrrolidin-1-yl]ethyl}-2-oxa-11,14-diazatricyclo[15.2.2.1~3,7~]docosa-1(19),3(22),4,6,17,20-hexaene-15-carboxamide | Formula: | C39 H39 F N4 O5 | Definition date: | 2021-04-28 | Last modified: | 2021-04-28 |
|
![PRD_002383 PRD_002383](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002383.svg) | PRD_002383 | Name: | des4.3.1 | Formula: | C44 H74 N12 O11 S | Definition date: | 2021-04-28 | Last modified: | 2021-04-28 |
|
![PRD_002362 PRD_002362](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002362.svg) | PRD_002362 | Name: | GsIN-1 peptide | Formula: | C79 H106 N16 O21 S | Definition date: | 2021-04-21 | Last modified: | 2021-04-21 |
|
![PRD_002397 PRD_002397](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002397.svg) | PRD_002397 | Formula: | C41 H72 N14 O10 S | Definition date: | 2021-03-31 | Last modified: | 2021-03-31 |
|
![PRD_002398 PRD_002398](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002398.svg) | PRD_002398 | Formula: | C42 H74 N14 O10 S | Definition date: | 2021-03-31 | Last modified: | 2021-03-31 |
|
![PRD_002399 PRD_002399](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002399.svg) | PRD_002399 | Formula: | C45 H68 N10 O11 S | Definition date: | 2021-03-31 | Last modified: | 2021-03-31 |
|
![PRD_002360 PRD_002360](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002360.svg) | PRD_002360 | Name: | myristoyl thiourea inhibitor, No. 23 | Formula: | C37 H67 N9 O5 S | Definition date: | 2021-03-24 | Last modified: | 2021-03-24 |
|
![PRD_002361 PRD_002361](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002361.svg) | PRD_002361 | Name: | myristoyl thiourea inhibitor, No.13 | Formula: | C39 H73 N12 O5 S | Definition date: | 2021-03-24 | Last modified: | 2021-03-24 |
|
![PRD_002460 PRD_002460](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002460.svg) | PRD_002460 | Formula: | C20 H39 N3 O5 | Description: | Calpain I inhibitor | Definition date: | 2021-02-24 | Last modified: | 2021-02-24 |
|
![PRD_900134 PRD_900134](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_900134.svg) | PRD_900134 | Name: | Blood group B H type 2 antigen, beta anomer | Formula: | C26 H45 N O20 | Description: | oligosaccharide with branches | Definition date: | 2021-02-17 | Last modified: | 2021-02-17 |
|
![PRD_002449 PRD_002449](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002449.svg) | PRD_002449 | Name: | (ACE)(1MH)D(B3L)F(1U8) | Formula: | C44 H54 N6 O12 | Definition date: | 2020-09-30 | Last modified: | 2020-09-30 |
|
![PRD_002450 PRD_002450](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002450.svg) | PRD_002450 | Name: | (ACE)(1MH)D(PF5)F(1U8) | Formula: | C46 H45 F5 N6 O12 | Definition date: | 2020-09-30 | Last modified: | 2020-09-30 |
|
![PRD_002372 PRD_002372](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002372.svg) | PRD_002372 | Name: | ACE-VAL-ARG-MET-QZA | Formula: | C22 H43 Cl N7 O5 S | Definition date: | 2020-09-16 | Last modified: | 2020-09-16 |
|
![PRD_002373 PRD_002373](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002373.svg) | PRD_002373 | Name: | ACE-VAL-ARG-MET-B2A | Formula: | C20 H41 B N7 O6 S | Definition date: | 2020-09-16 | Last modified: | 2020-09-16 |
|
![PRD_002352 PRD_002352](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002352.svg) | PRD_002352 | Formula: | C22 H31 N3 O7 | Definition date: | 2020-09-02 | Last modified: | 2020-09-02 |
|
![PRD_002315 PRD_002315](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002315.svg) | PRD_002315 | Name: | 4HP-PRO-LYS-ARG-NH2, BM-30 | Formula: | C25 H42 N8 O5 | Definition date: | 2020-08-26 | Last modified: | 2020-08-26 |
|
![PRD_002267 PRD_002267](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002267.svg) | PRD_002267 | Name: | D-Arg4,Leu10-Teixobactin | Formula: | C59 H101 N14 O14 | Definition date: | 2020-08-19 | Last modified: | 2020-08-19 |
|
![PRD_002187 PRD_002187](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/V66.svg) | PRD_002187 | Name: | tert-butyl [(4S,7S,10S)-7-(cyclohexylmethyl)-10-(hydroxymethyl)-5,8,13-trioxo-23-oxa-6,9,14,21,22-pentaazabicyclo[18.2.1]tricosa-1(22),20-dien-4-yl]carbamate | Formula: | C30 H50 N6 O7 | Definition date: | 2020-08-12 | Last modified: | 2020-08-12 |
|
![PRD_002189 PRD_002189](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/V64.svg) | PRD_002189 | Name: | tert-butyl [(4S,7S,10S)-7-(cyclohexylmethyl)-10-(hydroxymethyl)-5,8,13-trioxo-22-oxa-6,9,14,20,21-pentaazabicyclo[17.2.1]docosa-1(21),19-dien-4-yl]carbamate | Formula: | C29 H48 N6 O7 | Definition date: | 2020-08-12 | Last modified: | 2020-08-12 |
|
![PRD_002272 PRD_002272](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002272.svg) | PRD_002272 | Name: | (3R)-3,6-diamino-N-({(2R,5R,8Z,11S,15S)-15-amino-11-[(4R)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-8-[(carbamoylamino)methylidene]-2-methyl-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentaazacyclohexadecan-5-yl}methyl)hexanamide | Formula: | C25 H44 N14 O7 | Definition date: | 2020-08-12 | Last modified: | 2020-08-12 |
|
![PRD_002295 PRD_002295](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002295.svg) | PRD_002295 | Formula: | C89 H131 N23 O25 S3 | Definition date: | 2020-08-12 | Last modified: | 2020-08-12 |
|
![PRD_900060 PRD_900060](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_900060.svg) | PRD_900060 | Name: | ACARBOSE DERIVED HEXASACCHARIDE | Formula: | C36 H63 N O29 | Description: | oligosaccharide with N-glycosidic bond between monosaccharides | Definition date: | 2020-07-29 | Last modified: | 2020-08-05 |
|